Dolby Laboratories (DLB) EBITDA (2009 - 2026)

Dolby Laboratories' EBITDA history runs 18 years deep, the most recent figure standing at $112.9 million for Q1 2026.

• Quarterly EBITDA rose 4.81% year-over-year to $112.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $252.4 million (down 6.78% YoY) and the FY2025 annual result came in at $265.0 million, up 2.57% from the prior year.
• EBITDA was $112.9 million for Q1 2026 at Dolby Laboratories, up from $62.2 million in the prior quarter.
• Across five years, EBITDA topped out at $112.9 million in Q1 2026 and bottomed at -$3.5 million in Q3 2023.
• A 5-year average of $60.6 million and a median of $47.6 million in 2025 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2023 — EBITDA plunged 112.89% — and 2024, when it surged 1426.67%.
• Dolby Laboratories' EBITDA stood at $94.1 million in 2022, then slipped by 29.62% to $66.2 million in 2023, then gained by 20.63% to $79.9 million in 2024, then dropped by 22.18% to $62.2 million in 2025, then jumped by 81.7% to $112.9 million in 2026.
• Business Quant data shows DLB's EBITDA at $112.9 million in Q1 2026, $62.2 million in Q4 2025, and $29.7 million in Q3 2025.